REG - Ideagen PLC - Issue of Shares under SIP and TVR

Canaccord GenuityAnnouncement

11/02/2022 17:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220211:nRSK4997Ba&default-theme=true

RNS Number : 4997B  Ideagen PLC  11 February 2022

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

Issue of new shares under the Share Incentive Plan and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software
to highly regulated industries, announces that it has allotted a total of
3,413 new ordinary shares of 1 penny each in the capital of the Company
("Ordinary Shares") following the purchase of 3,413 Ordinary Shares in
aggregate by a number of employees under the Company's Share Incentive Plan
("SIP").

Application has been made to the London Stock Exchange for the 3,413 new
Ordinary Shares to be admitted to trading on AIM ("Admission") and it is
expected that Admission will become effective and trading will commence at
8.00 a.m. on 17(th) February 2022.

After Admission, the total number of Ordinary Shares in issue will be
293,695,490 and the total number of voting rights will therefore be
293,695,490. This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the share capital of the
Company under the FCA's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Regulation
11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

Enquiries:

 Ideagen plc                          01629 699 100
 Ben Dorks, Chief Executive Officer
 Emma Hayes, Chief Financial Officer

 Canaccord Genuity Limited (Nomad)    020 7523 8000
 Simon Bridges
 Georgina McCooke

 finnCap Limited                      020 7220 0500
 Henrik Persson/James Thompson
 Alice Lane

 Numis Securities Limited             0207 260 1267
 Simon Willis
 Joshua Hughes

 FTI Consulting                       020 3727 1000
 Jamie Ricketts                       ideagen@fticonsulting.com
 Dwight Burden
 Valerija Cymbal

 

 

About Ideagen plc

Ideagen's software helps companies comply with regulation and manage risk.

Ideagen is a leader in the +$30 billion regulatory and compliance software
market, serving highly regulated industries such as life sciences, healthcare,
banking and finance and insurance.

More than 8,000 customers use Ideagen's software, including 9 of the top 10 UK
accounting firms, all of the top aerospace and defence companies and 75% of
leading pharmaceutical firms.

Ideagen has a diversified customer base including blue chip, global brands
such as Heineken, British Airways, BAE, Aggreko, US Navy, Bank of New York and
Johnson Matthey, as well as 250 hospitals across the UK and US.

Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM
market (Ticker: IDEA.L), and has key hubs in the UK, USA, Middle East and
South East Asia.  For further information please visit www.ideagen.com
(http://www.ideagen.com/) .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFLFVDFSILLIF